跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dopalink
Approved
STANDARD
Dopalink
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b859b4aa45aa4279
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
b859b4aa45aa4279
Drug Approval Philippines Name
Dopalink
Product Name
Dopalink
Registration Number
DRP-3655-02
Brand Name
Dopalink
Generic Name
Methyldopa (As Sesquihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
250 mg
Manufacturer
Lloyd Laboratories, Inc.
Importer
Totalcare Pharma, Inc.
Distributor
Vitalink Health Product, Inc.
Issuance Date
25 June 2021
Expiry Date
27 May 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b859b4aa45aa4279
Type
Standard
Back to Philippines FDA Approvals
Dopalink - Philippines FDA Drug Approval Details